NASDAQ
EXAI

Exscientia Ltd ADR

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Exscientia Ltd ADR Stock Price

Vitals

Today's Low:
$5.52
Today's High:
$5.76
Open Price:
$5.76
52W Low:
$4.09
52W High:
$16.45
Prev. Close:
$5.69
Volume:
188804

Company Statistics

Market Cap.:
$949.99 million
Book Value:
3.894
Revenue TTM:
$32.18 million
Operating Margin TTM:
-705.94%
Gross Profit TTM:
$10.25 million
Profit Margin:
0%
Return on Assets TTM:
-16.24%
Return on Equity TTM:
-22.71%

Company Profile

Exscientia Ltd ADR had its IPO on 2021-10-01 under the ticker symbol EXAI.

The company operates in the Healthcare sector and Biotechnology industry. Exscientia Ltd ADR has a staff strength of 481 employees.

Stock update

Shares of Exscientia Ltd ADR opened at $5.76 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $5.52 - $5.76, and closed at $5.56.

This is a -2.28% slip from the previous day's closing price.

A total volume of 188,804 shares were traded at the close of the day’s session.

In the last one week, shares of Exscientia Ltd ADR have slipped by -9.89%.

Exscientia Ltd ADR's Key Ratios

Exscientia Ltd ADR has a market cap of $949.99 million, indicating a price to book ratio of 1.0044 and a price to sales ratio of 23.3243.

In the last 12-months Exscientia Ltd ADR’s revenue was $32.18 million with a gross profit of $10.25 million and an EBITDA of $-217494656. The EBITDA ratio measures Exscientia Ltd ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Exscientia Ltd ADR’s operating margin was -705.94% while its return on assets stood at -16.24% with a return of equity of -22.71%.

In Q1, Exscientia Ltd ADR’s quarterly earnings growth was a positive 0% while revenue growth was a negative 17.7%.

Exscientia Ltd ADR’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Exscientia Ltd ADR’s profitability.

Exscientia Ltd ADR stock is trading at a EV to sales ratio of 3.0537 and a EV to EBITDA ratio of 0.473. Its price to sales ratio in the trailing 12-months stood at 23.3243.

Exscientia Ltd ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$603.29 million
Total Liabilities
$70.60 million
Operating Cash Flow
$0
Capital Expenditure
$12.77 million
Dividend Payout Ratio
0%

Exscientia Ltd ADR ended 2024 with $603.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $603.29 million while shareholder equity stood at $447.72 million.

Exscientia Ltd ADR ended 2024 with $0 in deferred long-term liabilities, $70.60 million in other current liabilities, 62000.00 in common stock, $-13053000.00 in retained earnings and $6.27 million in goodwill. Its cash balance stood at $195.41 million and cash and short-term investments were $447.37 million. The company’s total short-term debt was $3,394,000 while long-term debt stood at $311000.00.

Exscientia Ltd ADR’s total current assets stands at $496.38 million while long-term investments were $2.30 million and short-term investments were $251.96 million. Its net receivables were $41.00 million compared to accounts payable of $15.07 million and inventory worth $89750.00.

In 2024, Exscientia Ltd ADR's operating cash flow was $0 while its capital expenditure stood at $12.77 million.

Comparatively, Exscientia Ltd ADR paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$5.56
52-Week High
$16.45
52-Week Low
$4.09
Analyst Target Price
$14.75

Exscientia Ltd ADR stock is currently trading at $5.56 per share. It touched a 52-week high of $16.45 and a 52-week low of $16.45. Analysts tracking the stock have a 12-month average target price of $14.75.

Its 50-day moving average was $6.87 and 200-day moving average was $6.37 The short ratio stood at 7.04 indicating a short percent outstanding of 0%.

Around 2787.7% of the company’s stock are held by insiders while 2828.9% are held by institutions.

Frequently Asked Questions About Exscientia Ltd ADR

The stock symbol (also called stock or share ticker) of Exscientia Ltd ADR is EXAI

The IPO of Exscientia Ltd ADR took place on 2021-10-01

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
Sunrun Inc (RUN)
$14.63
0.91
+6.63%
$482.25
-22.4
-4.44%
$139.9
-3.74
-2.6%
$2.19
0
0%
$32.36
0.27
+0.84%
$11.58
-0.06
-0.52%
$13.51
0.03
+0.22%
$21.98
-1.02
-4.43%
$718.45
-16.45
-2.24%
$5.22
-0.11
-2.06%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company’s platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Address

The SchrOedinger Building, Oxford, United Kingdom, OX4 4GE